Under this arrangement, The Charlesworth Group will support The Company of Biologists by overseeing its subscription and site licensing activities in the market, and helping to maximize and increase revenue streams through dedicated sales and marketing initiatives.


Company of Biologist


Speaking of the new partnership, Michael Evans, Global CEO at The Charlesworth Groupcomments: "The Company of Biologists' journal portfolio comprises a strong suite of high-impact life sciences titles. We look forward to enhancing their collective profiles in China via our targeted marketing approach and initiatives put into place by our dedicated sales team on the ground. Working closely with The Company of Biologists' staff on strategy, and maintaining detailed activity analysis via our dedicated CRM, we are confident that we will achieve market growth and enhanced brand awareness at both a journal - and organizational level."


Richard Grove, Sales Manager at The Company of Biologists says: "I am delighted to be working with The Charlesworth Group in China and have great confidence in their ability to grow and maintain both new and existing business in the region."

For more information on how Charlesworth Representation Services can help maximize revenues and brand visibility in the Chinese academic market, please contact marketing@charlesworth-group.com.


About The Company of Biologists

The Company of Biologists is a not-for-profit publishing organization dedicated to supporting and inspiring the biological community.  It is run by distinguished practising scientists who exist to profit science, inspire new thinking and support the community of biologists. For further information, please visit www.biologists.com.


About The Charlesworth Group

The Charlesworth Group is a high-quality publishing services company, specializing in the academic and professional sectors. Our core services include consultancy, sales and marketing within the Chinese market and editorial and publication support such as English language editing. For further information, please contact us.

Share with your colleagues